Samir H. Moussa

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Thomas F. Durand-Réville, Satenig Guler, Janelle Comita-Prevoir et al. · Nature Microbiology · 2017 · 262 citations

Bacterial Resistance, Antimicrobial Susceptibility, Health Sciences +12

Rational design of a new antibiotic class for drug-resistant infections

Thomas F. Durand-Réville, Alita A. Miller, John P. O’Donnell et al. · Nature · 2021 · 134 citations

Antimicrobial Susceptibility, Antibiotics, Rational Design +8

Targeting Multidrug-Resistant <i>Acinetobacter</i> spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent

Melissa D. Barnes, Vijay Kumar, Christopher R. Bethel et al. · mBio · 2019 · 114 citations · Full text

Compound-gene interaction mapping reveals distinct roles for<i>Staphylococcus aureus</i>teichoic acids

John P. Santa Maria, Ama Sadaka, Samir H. Moussa et al. · Proceedings of the National Academy of Sciences · 2014 · 110 citations · Full text

A new platform for ultra-high density Staphylococcus aureus transposon libraries

Marina Santiago, Leigh M. Matano, Samir H. Moussa et al. · BMC Genomics · 2015 · 105 citations · Full text